You are here

  • Home
  • Archive
  • Volume 105, Issue 6
  • Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients

Article info

Article menu
Download PDFPDF
Clinical science
Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients

Authors

  1. Correspondence to Won Kyung Song, Department of Ophthalmology, CHA Bundang Medical Center, 55. CHA University Seongnam, The Republic of Korea; songwkmd{at}daum.net
View Full Text

Citation

Sung Y, Lee MJ, Choi J, et al
Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients
British Journal of Ophthalmology 2021;105:829-837.

Publication history

  • Received March 4, 2020
  • Revised June 18, 2020
  • Accepted June 21, 2020
  • First published July 29, 2020.
Online issue publication 
May 20, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.